Pneumococcal meningitis in the era of pneumococcal conjugate vaccine implementation

By Bingen E.   Levy C.   Varon E.   Rocque F.   Boucherat M.   d’Athis P.   Aujard Y.   Cohen R.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Iss. 3, 2008-03 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Serotype-specific problems associated with pneumococcal conjugate vaccination

By Hanage William P  

Future Microbiology, Vol. 3, Iss. 1, 2008-02 ,pp. : 23-30

Future Medicine

Access to resources Recommend Favorite

Protein conjugate vaccines - how much is enough?

By Obaro S.K.  

Trends in Microbiology, Vol. 9, Iss. 8, 2001-08 ,pp. : 364-365

Elsevier

Access to resources Recommend Favorite

Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine

By Aristegui J.   Bernaola E.   Pocheville I.   García C.   Arranz L.   Durán G.   Pérez L.   Bastida M.   Canduela C.   Herranz Aguirre M.   Garrote E.   Fletcher M.   Pérez C.  

European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Iss. 5, 2007-05 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

Serotype distribution of invasive Streptococcus pneumoniae in Canada during the introduction of the 13-valent pneumococcal conjugate vaccine, 2010

By Demczuk Walter H.B.   Martin Irene   Griffith Averil   Lefebvre Brigitte   McGeer Allison   Shane Amanda   Zhanel George G.   Tyrrell Gregory J.   Gilmour Matthew W.      

Canadian Journal of Microbiology, Vol. 58, Iss. 8, 2012-08 ,pp. : 1008-1017

NRC Research Press

Access to resources Recommend Favorite